156 related articles for article (PubMed ID: 2410995)
21. The significance of fibrinogen derivatives in plasma in human renal failure.
Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
[TBL] [Abstract][Full Text] [Related]
22. Platelet and fibrin metabolism in recipients of the Jarvik 7 total artificial heart.
Ring ME; Feinberg WM; Levinson MM; Bruck DC; Smith RG; Icenogle TM; Copeland JG
J Heart Transplant; 1989; 8(3):225-32. PubMed ID: 2525612
[TBL] [Abstract][Full Text] [Related]
23. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
Marongiu F; Mamusa AM; Mameli G; Conti M; Sorano GG; Biondi G; Farci P; Balestrieri A
Ric Clin Lab; 1989; 19(2):157-63. PubMed ID: 2528202
[TBL] [Abstract][Full Text] [Related]
24. [Activity of the coagulation and fibrinolysis in non-insulin-dependent diabetes mellitus. In vivo study].
Conti M; Marongiu F; Mameli G; Mamusa AM; Cambuli AB; Cossu E; Sorano GG; Biondi G; Cirillo R; Balestrieri A
Recenti Prog Med; 1989 Jun; 80(6):297-9. PubMed ID: 2772395
[TBL] [Abstract][Full Text] [Related]
25. Prospective double-arm study of fibrinolysis in surgical patients.
Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
[TBL] [Abstract][Full Text] [Related]
26. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
27. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
[TBL] [Abstract][Full Text] [Related]
28. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
29. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
30. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Al-Mondhiry H; Pierce WS; Pennock JL
J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of fibrinopeptide A in surgery].
Fuwa S
Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
[TBL] [Abstract][Full Text] [Related]
33. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
34. [Beta-thromboglobulin and fibrinopeptide A in acute myocardial infarction].
Cassetti M; Palazzesi G; Materazzi M; Massoli PD
Quad Sclavo Diagn; 1985 Jun; 21(2):173-81. PubMed ID: 2417270
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
36. Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy.
Widström O; Kockum C; Nilsson BS
Scand J Respir Dis; 1978 Aug; 59(4):210-5. PubMed ID: 694476
[TBL] [Abstract][Full Text] [Related]
37. The effect of low-dose heparin on fibrinopeptide A, platelets, fibrinogen degradation products and other haemostatic parameters measured in connection with intestinal surgery.
Törngren S; Norén I; Savidge G
Thromb Res; 1979; 14(6):871-9. PubMed ID: 382435
[No Abstract] [Full Text] [Related]
38. [Relation between blood coagulability and prognosis in patients with ovarian cancer].
Sawaguchi K; Narumiya H; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):313-9. PubMed ID: 2358716
[TBL] [Abstract][Full Text] [Related]
39. Plasma betathromboglobulin and serum fragment E in acute partial stroke.
de Boer AC; Turpie AG; Butt RW; Duke RJ; Bloch RF; Genton E
Br J Haematol; 1982 Feb; 50(2):327-34. PubMed ID: 6174141
[TBL] [Abstract][Full Text] [Related]
40. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
